RTTNews | Oct 7, 2020 06:50AM EDT

06:50 Wednesday, October 7, 2020 (RTTNews) - Pfizer, Sangamo Dose First Participant In Phase 3 AFFINE Study Of Giroctocogene Fitelparvovec For Hemophilia A Patients

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved